An analysis of 1019 samples in the Cancer Cell Line Encyclopaedia64 using cBioPortal65 showed that many canonical NFE2L2 targets were found among top transcripts co-expressed with LINC00942, including among others GCLM at rank 6 and TXNRD1 at rank 14, further establishing NFE2L2-dependent expression of LINC00942. The annotated transcription initiation site was supported by RNA polymerase II chromatin immunoprecipitation (ChIP) data from ENCODE, and an upstream regulatory region was further indicated by DNase I hypersensitivity and FAIRE signals (Fig. 6a). This evidence concerns the gene NFE2L2 and cancer.